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(61, 62, and 63). Also, three of our patients who
were operated on had small aneurysms initially
that grew by over 1 cm in six months, a far quicker
rate ofgrowth than that described by others in non-
hypertensive patients.
On the basis of our initial findings we believe
that screening should be offered to male hyper-
tensive patients from the age of 60 and should be
done regularly-for example, every three to five
years-in this group.
In the 388 women we have screened eight
aneurysms have been detected (only two over
3 5 cm), confirming the low incidence ofaneurysms
in women described by others.3 One woman, aged
72, has required an elective repair of an aneurysm
of 6 1 cm. Many more hypertensive women will
require screening to determine more precisely the
lower incidence of aneurysms in this group. Offer-
ing screening in some form to this group may well,
however, prove to be just as economical as breast
cancer screening, in terms of quality adjusted life
years at least.
Numerous studies have suggested an association
between hypertension and abdominal aortic
aneurysms. We believe that hypertensive people
also "require special provision for screening irres-
pective of any plans to screen apparently healthy
people."
MARTIN SOWTER
MICHAEL LEWIS
Department of Surgery,
East Glainorgan Hospital,
Pontypridd,
Mid-Glamorgan CF38 lAB
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EDITOR,-I am sympathetic to P L Harris's ob-
jective of trying to reduce mortality from ruptured
abdominal aortic aneurysms.' I have recently
screened 678 (97-6%) of the 695 patients aged
60-79 in our practice for aneurysms. Twenty six
were found to have an aneurysm (range 3 0-8 3 cm
external sagittal diameter), and 13 were referred
for a surgical opinion. The screening programme
has exposed some of the dilemmas in current
management of aneurysms.
Patients deserve to know of important risks
associated with repair of an aneurysm. Harris's
statement that in the best centres elective repair
carries an "operative risk of under 5%" cannot be
generally assumed, and published mortality
statistics may not reflect the risk for an average
patient.2 Morbidity associated with elective repair
of an aneurysm has not been widely published, but
in series of mixed elective and emergency repairs
it has been considerable. Without reference
statistics on mortality and morbidity the balance of
when to operate for a particular size of aneurysm
and risk to the patient becomes uncomfortably
difficult. For individual patients local results
will be most pertinent unless distant referral is
considered.
Harris rightly directs attention to aneurysms of
4-0-5-0 cm, for which management is contentious;
most aneurysms detected by screening fall into
this category. Surgery has been advocated for
aneurysms of >4 cm,6 but such an aggressive
policy is not supported by recent prospective78 and
retrospective9 studies of the natural course of
aneurysm. Rarely, small aneurysms will rupture
fatally, but I believe that relatives find unlikely
natural tragedy easier to bear than tragedy after
well intentioned surgery. A more conservative
approach to surgery tips the risk-benefit balance
towards benefit, and Scott et al's study exemplifies
how such a policy has worked successfully.'
With regard to the psychological consequences
of detecting aneurysms by screening, will patients
with small aneurysms be able to maintain a fair
perspective of a low risk of rupture or will their
predominant perception be of a time bomb waiting
to explode within? The predicament of those with
large aneurysms who are considered to be unfit
for surgery is particularly unfortunate. The
anxiety an aneurysm can generate should not be
underestimated or disregarded.
If a low mortality and morbidity associated
with elective surgery, a conservative approach to
intervention, and adequate counselling of patients
can be combined then I believe that a local
screening policy for aneurysms could make good
ethical and-economical sense. That such criteria
apply nationally is doubtful, and currently I do not
favour a national screening programme.
Lastly, 0 blockade has shown promise in the
management of aneurysms. As aneurysms are
common, whether physiological fil adrenergic
antagonism can retard their expansion or reduce
the rate of rupture is of great practical importance.
An extension of the Medical Research Council's
small aneurysm study to address this issue would
be expedient.
J S ROSE
The Surgery,
Lindford,
Hampshire GU35 OQJ
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Domiciliary thrombolysis by
general practitioners
EDITOR, -The results of the Grampian region
early anistreplase trial' need to be seen within the
context of the burden of myocardial infarction that
is carried by a community. The general practi-
tioners who participated clearly, and effectively,
performed a great deal of selection. Recruitment
of one patient every 11 months means that
most patients with myocardial infarction were
not entered into the trial. A local estimate for
Plymouth Health Authority is of eight to 10
myocardial infarctions per general practitioner
each year; on the basis of the lower figure, and
assuming a 30% death rate if medical help is not
called, these general practitioners' patients would
have suffered 1537 myocardial infarctions, but
only 311 were recruited.
Another way of looking at this is to consider the
total number of deaths ascribed to myocardial
infarction among patients of the doctors in the
study. Extrapolation from local data for Plymouth
gives an estimate of 1060 deaths over the period of
the study. A considerable proportion of these will
have been sudden deaths; this still leaves many
more deaths than those noted during the study.
Any strategy for implementing a new advance
needs to take into account the whole range of
presentations of conditions; for thrombolysis this
means not only patients with classical myocardial
infarction diagnosed by general practitioners but
also, for example, people with atypical chest pain
and those who do not perceive their symptoms as
serious.
ALISON ROUND
Plymouth Health Authority,
Plymouth PL6 5XN
I GREAT Group. Feasibility, safety, and efficacy of domiciliary
thrombolysis by general practitioners: Grampian region early
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EDITOR,-I am surprised that in the Grampian
region early anistreplase trial no patients were
diagnosed as having unstable angina, which is the
most common differential diagnosis and the most
difficult to make in the early stages of a myocardial
infarction.' It is likely that the patients in the
diagnostic groups "possible myocardial infarction"
and "ischaemic heart disease" in fact had unstable
angina. If only definite and probable myocardial
infarctions are counted the diagnostic accuracy of
the general practitioners was 57% (and of the
hospital doctors 66%). This may also account for
the lower mortality and fewer Q wave infarctions in
the domiciliary group.
As there is no evidence that thrombolytic treat-
ment is of benefit in unstable angina2 it seems that
nearly half the patients in the study received
thrombolytic treatment inappropriately and were
needlessly exposed to the risks of haemorrhage.
Colleagues and I found similar figures in a
study in Somerset, where the general practitioners
accurately diagnosed myocardial infarction on
clinical grounds (without electrocardiography in
most cases) in 45% of cases (S Rule et al, un-
published work). Again this was largely because
many patients with unstable angina were thought
to be in the early stages of myocardial infarction.
Diagnosing myocardial infarction at the onset
can be difficult, but at a minimum a good history
should be obtained and an electrocardiogram
properly interpreted. In the Grampian study the
general practitioner was required to record an
electrocardiogram but not to interpret it, which
seems pointless. It is the electrocardiogram, how-
ever, that causes problems for many general
practitioners as individually they will see few cases
of myocardial infarction each year. The higher
diagnostic accuracy in hospital may relate to this.
JOHN E SANDERSON
Taunton and Somerset Hospital,
Taunton,
Somerset TA I 5DA
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EDITOR,-The Grampian region early anistreplase
trial provides a valuable contribution to the debate
on pre-hospital thrombolysis, particularly in view
of the importance of minimising the delay to
treatment.' Several points merit additional discus-
sion. Although the authors state that about 60% of
eligible patients were recruited into the study, they
do not state the proportion of all patients with
myocardial infarction. The narrow time window
for entry to the trial selected patients presenting
early. Indeed, the median patient delay in an
earlier community study by the same authors was
two hours,2 compared with 45 minutes in this
study. Thus the improvements in outcome may
not necessarily apply to patients presenting later.
The median delay to presentation in recent large
scale studies has been substantially longer (57%
beyond four hours in the second international
study of infarct survival').
The high accuracy of diagnosis achieved in this
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study in the absence of electrocardiographic
criteria is not necessarily generally applicable.
Unless thrombolvsis is restricted to those present-
ing early and with classic symptoms of infarction,
the proportion of alternative diagnoses (2-2%) is
unlikely to be substantiated. For example, phase 1
of the myocardial infarction triage and intervention
project found only one in six confirmed infarctions
among those evaluated before admission to
hospital.'
The statement that "even in an urban area there
would be a temporal advantage in the general
practitioner giving thrombolytic therapy in the
home" is untested and cannot be extrapolated from
the present study. A 999 call and shortening of
the delays in hospital would have reduced the
difference between home and hospital treatment
substantially. We have shown that in an urban
area the time of administration of thrombolytic
treatment after the onset ofsymptoms was reduced
to a median of 150 minutes by the introduction of a
"fast track" system.'
Until these issues are resolved it may be pre-
mature to advise the widespread implementation
of pre-hospital thrombolysis without electro-
cardiographic confirmation.
A C H PELL
K A A FOX
Cardiovascular Research Unit,
Edinburgh University,
Edinburgh EH8 9XP
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EDITOR,-Much publicity has been, and will be,
given to the finding of the Grampian region
early anistreplase trial that patients who received
thrombolytic treatment (anistreplase) at home had
49% fewer deaths than those who received it
in hospital.' Unfortunately, the trial was really
too small to estimate reliably any reduction in
mortality, and so significance could be achieved
only if (because of either chance or bias) an im-
plausibly large treatment difference was observed.
In such circumstances a bayesian analysis provides
a useful interpretation by setting a surprising
finding in the context of more cautious prior
belief.2
First one expresses prior belief about the pro-
portionate reduction in mortality due to thrombo-
lysis at home. Given the known benefits of early
thrombolysis' 4 and the average two hours saved in
time to treatment, it could be argued that a 15-20%
reduction in mortality is highly plausible, while the
extremes of no benefit and a 40% reduction are
both unlikely. The figure (a) shows such a distri-
bution of prior belief. This prior is compatible with
the results of the European myocardial infarction
project, in which the same drug was given to over
5000 patients.
In the Grampian region early anistreplase trial
23 of the 148 patients who received home thrombo-
lysis died within three months compared with 13 of
the 163 who received hospital thrombolysis. This
is displayed in the figure (b). The observed 49%
reduction is the mode of this distribution, and the
2% tail area beyond no effect indicates p=0-02 one
sided. The widely spread distribution illustrates
the inevitable uncertainty with only 36 deaths in
total.
Using Bayes's theorem, we have combined the
prior belief and likelihood to produce a posterior
belief distribution (figure (c)). This quantifies how
opinion on the efficacy of home thrombolysis
should be affected by the limited amount of highly
positive data in the Grampian region early anistre-
plase trial. The peak of the posterior distribution
is a 25% reduction in mortality, with a 95%
confidence interval from no effect to a 43% reduc-
tion. Thus belief is shifted in a positive direction,
but not by much, and, specifically, a halving of
mortality remains implausible.
(a) Prior distribution
I t l
(b) Likelihood based on
23/148 v 13/163 deaths
(c) Posterior distribution
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Bayesian analysis of data from Grampian region early
anistreplase trial
Perhaps the Grampian region early anistreplase
trial was just lucky. For instance, based on the
figure (a) a difference of 23 versus 13 deaths or
more should occur with probability 0-1. We are
also concerned, however, about the emphasis
on three month mortality (not a predefined end
point), the lack of independent monitoring of data,
the randomisation method, and the early stopping
of the trial.
Overall, such an important therapeutic issue
requires larger scale trials which can quantify the
treatment effect precisely. Here we seem faced
with publication bias. A small positive trial (the
Grampian region early anistreplase trial) gets
emphasised while another larger trial of the same
issue (the European myocardial infarction project)
remains unpublished. On a broader note, we
would encourage a wider use of bayesian methods
in reports of clinical trials, especially when a small
trial is claiming a large treatment benefit.
STUART J POCOCK
Medical Statistics Unit,
London School of Hygiene and Tropical Medicine,
London WC I E 7HT
DAVID J SPIEGELHALTER
MRC Biostatistics Unit,
Institute of Public Health,
Cambridge CB2 2SR
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On site medical services at
major incidents
EDITOR,-Matthew W Cooke' and D G Nancekie-
vill2 emphasise the need for better organisation and
training for hospital staff in providing on site
medical services when a major incident occurs.
A hospital coping with a deluge of casualties
from a major incident might be overstretched in
providing one or more appropriate teams as well as
a doctor senior enough to be the medical incident
officer (the Department of Health has abandoned
the term site medical officer). Cooke highlights the
paucity of training in this role. Wide ranging
discussions have taken place in London with
representatives of the London accident and emer-
gency consultants' group, the London Ambulance
Service, the British Association for Immediate
Care, and health emergency planning officers from
each Thames regional health authority with the
aim of creating a cadre of 40-50 trained and
accredited medical incident officers. This scheme
relieves the main receiving hospital of the onerous
duty of providing all the resources required at
the site. The scheme has been approved by all
participants, but, in view of its variation from
guidance from the Department of Health, indi-
vidual units will retain the option of making their
own arrangements.
Two established training courses for doctors are
available nationally. A one day course is run by the
British Association for Immediate Care each year
in Cambridge, and a three day course on the
medical management of major incidents is run
jointly by the Royal Postgraduate Medical School
and the British Association for Immediate Care at
Hammersmith Hospital. This course is multi-
disciplinary and combines lectures, seminars, and
practical training for NHS staff called on to work
as medical incident officers or with mobile medical
and nursing teams. In the two years that the course
has been run, 102 people have been trained. The
participants undertake an assessment at the end of
the course, a major function ofwhich is to allow the
course organisers to assess the effectiveness of the
training offered in key principles.
Though advanced trauma life support courses
offer excellent training in clinical aspects, specific
training is required for all prehospital care,
including elements of safety and working with the
emergency services.
ROBERT A COCKS
Royal Postgraduate Medical School,
Hammersmith Hospital,
London W 12 OHS
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EDITOR,-We agree with D G Nancekievill that
both medical incident officers and site medical
teams for major incidents need to be trained and to
be familiar with the procedures of the other
emergency services.' We disagree that training is a
problem. The British Association for Immediate
Care has been training doctors in this work for
many years.
The association produced its first guide to
managing major incidents in 1985,2 and the skills
of doctors trained by the association were recog-
nised in the report on the railway accident
at Clapham.3 The association's interservice and
disaster liaison committee has been working with
the ambulance, police, and fire services and the
armed forces, coastguard, mountain rescue ser-
vices, and, latterly, the Home Office adviser on
civil emergencies on all aspects of managing major
incidents. The association hopes to produce guide-
lines on the medical aspects of managing major
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